Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.17 (
CaMKII
)
4,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Annexin VI
bound to > 14 species of proteins in the whole homogenate of rat forebrain in a Ca2+/phosphatidylserine- or phosphatidic acid-dependent manner. When the subcellular fractions of rat forebrain were examined with a blot from a sodium dodecyl sulfate-polyacrylamide gel, each
annexin VI
-binding protein showed a different distribution, suggesting that
annexin VI
is a multifunctional protein. Of these proteins, the doublets of M(r) 80,000 were enriched in the purified synaptic vesicles and were identified as synapsin I.
Annexin VI
bound to the head domain of synapsin I. When the binding of
annexin VI
to synapsin I was characterized in the native state, the affinity of the binding for Ca2+ (KCa) was 12.6 microM, and the affinity for
annexin VI
(KD) was approximately 270 nM. Phosphorylation of synapsin I by cyclic AMP-dependent protein kinase and by
Ca2+/calmodulin-dependent protein kinase II
inhibited the
annexin VI
binding. The mode of the inhibition was different between the two kinases. These results indicate that
annexin VI
may modulate the function of synapsin I in a Ca(2+)- and phospholipid-dependent manner.
...
PMID:Annexin VI binds to a synaptic vesicle protein, synapsin I. 793 47